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Abstract6-Mercaptopurine is a thiopurine-derivative antimetabolite, which is used for the treatment of cancer, ulcerative colitis, Crohn’s disease, and autoimmune diseases. The aim of this research work was to evaluate the impact of the Trivedi Effect® on the physicochemical, and thermal properties of 6-mercaptopurine using the modern analytical technique. 6-Mercaptopurine powder sample was divided into two parts. One part of the sample 
was considered as a control sample (no Biofield Energy Treatment was provided), whereas the other part was treated with Biofield Energy Treatment 
remotely by a renowned Biofield Energy Healer, Dahryn Trivedi and termed as a treated sample. The particle size values in the treated 6-mercaptopurine 
powder sample were significantly decreased by 5.72%(d10), 5.16%(d50), 3.75%(d90), and 4.54%{D(4,3)}; therefore, the specific surface area was 
increased by 4.76% compared to the control sample. The PXRD peak intensities and crystallite sizes of the treated powder sample were significantly 
altered ranging from-25% to 14.12% and-35.09% to 71.3%, respectively; whereas the average crystallite size was decreased by 2.77% compared 
with the control sample. The latent heat of evaporation and latent heat of fusion of the treated sample was significantly altered by 3.05% and-39.48% 
compared with the control sample. The total weight loss was significantly increased by 9.72%; however, the residue amount was significantly decreased 
by 79.89% in the treated sample compared with the control sample. The maximum thermal degradation temperature of the 1st, 2nd, and 3rd peaks of 
the treated sample was increased by 1.54%, 0.13%, and 5.56% compared with the control sample. From the results, it was concluded that the biofield energy treatment might have generated a new polymorphic form of 6-mercaptopurine which may offer better solubility, dissolution, absorption, and 
bioavailability compared with the control sample. The Biofield Energy Treated 6-mercaptopurine would be very useful to design better pharmaceutical formulations that might offer better therapeutic response against acute lymphocytic leukemia, chronic myeloid leukemia, ulcerative colitis, Crohn’s disease, and autoimmune diseases. 
Keywords: 6-mercaptopurine; The Trivedi Effect®; Consciousness Energy Healing Treatment; Complementary and alternative medicine; Particle size; 
Surface area; PXRD; DSC; TGA/DTG
Introduction
Mercaptopurine (1,7-dihydro-6H-purine-6-thione) is a thiopu-rine-derivative antimetabolite used for the treatment of cancer and autoimmune diseases. The mechanism of action involves inhibition of purine nucleotide synthesis and metabolism by obstructing an 
enzyme called phosphoribosyl pyrophosphate aminotransferase interference [1,2]. It is used alone or with other anti-cancer drugs for the treatment of acute lymphocytic leukaemia, chronic my-eloid leukaemia, ulcerative colitis, Crohn’s disease, and autoim-
mune diseases [3-5]. It was listed as Essential Medicines by the 
World Health Organization and approved for medical use in the 
USA since from 1953 [6]. Adverse effects associated with the use of 6-mercaptopurine therapy are nausea, vomiting, loss of appe-tite, diarrhoea, stomach and abdominal pain, mouth sores, fatigue, weakness, fever, sore throat, skin rash, yellowing of skin or eyes, 
 red spots on the skin, darkening of the skin, hair loss, easy bruising or bleeding, black stools, bloody stools, bloody urine, dark urine, 
painful or difficult urination may suppress the production of both red and white blood cells, and can be linked to the genetic polymor-
phisms [7-9]. Different mercaptopurine pharmaceutical formulations are available for the oral route of administration are tablets and liquid suspensions [10-12]. The 6-mercaptopurine in water, acetone, chloroform, and diethyl ether is insoluble; slightly soluble in dilute sulphuric acid, but in hot alcohol and dilute alkali solutions it is soluble [12]. In order to improve the solubility, dissolution, absorption, and bioavailability of the pharmaceutical and nutraceutical compounds, scientists throughout the globe doing the 
extensive research work [13]. On this aspect, the Trivedi Effect®-
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biofield energy healing treatment (biofield energy treatment) 
appealed to have the significant impact on the crystallite size, 
particle size, surface area, thermal behaviour, and bioavailability 
profile of pharmaceutical and nutraceutical compounds [14-17]. The Trivedi Effect® is a natural and only scientifically established phenomenon in which an individual can harness this inherently intelligent energy from the “Universe” and transfer it anywhere on the planet through the possible mediation of neutrinos [18]. 
There is an infinite and Para dimensional electromagnetic field 
exists surrounding the body of every living organism generated due to continues moment of the charged particle inside the body (i.e., 
ions, cells, blood flow, etc.) is called Biofield. The Complementary 
and Alternative Medicine (CAM) therapies has been recognized 
by the National Centre of Complementary and Integrative Health 
(NCCIH), which include meditation, yoga, Reiki, hypnotherapy, 
Ayurvedic medicine, traditional Chinese herbs and medicines in biological systems, etc., that has been accepted by the most of 
the USA people [19,20]. The CAM therapies including Biofield 
Energy Treatment is an emerging field for the improvement of the quality of life and various health conditions [21,22]. Likewise, the Trivedi Effect®-Consciousness Energy Healing Treatment 
has a significant impact on the physicochemical, structural, and 
behavioural properties of metals, ceramics, and polymers [23 25], 
organic compounds [26,27], microorganisms [28,29], cancer cells 
[30,31], and improve the overall productivity of crops [32,33]. Seeing all these outstanding results, the current study was designed 
to evaluate the influence of the Consciousness Energy Healing Treatment (Trivedi Effect®) on the physicochemical, thermal, 
and behavioural properties of mercaptopurine using particle size 
analysis, powder X-ray diffraction, differential scanning calorimetry, 
and thermogravimetric analysis/ differential thermogravimetric analysis.
Materials and Methods 
Chemicals and Reagents6-Mercaptopurine monohydrate was purchased from Tokyo Chemical Industry Co., Ltd., Japan and the other chemicals were of analytical grade purchased in India.
Consciousness Energy Healing Treatment Strategies6-mercaptopurine powder sample was divided into two equal parts. One part of the test sample was treated with the Trivedi Effect®- Consciousness Energy Healing Treatment  remotely under 
standard research laboratory conditions for 3 minutes by the 
renowned biofield energy healer, Dahryn Trivedi  (USA), and known 
as a Biofield Energy Treated sample. However, the second part of 
the test sample did not provide Biofield Energy Treatment and considered as a control sample. But the control sample was treated with a “sham” healer and the sham healer totally ignorant about 
the biofield energy treatment. After the treatment, the treated and 
untreated samples were kept in sealed conditions and characterized 
using PSA, PXRD, DSC, and TGA/DTG analytical techniques. 
Characterization
The PSA, PXRD, DSC, and TGA analysis of 6-mercaptopurine 
were performed. The PSA was performed with the help of Malvern 
Mastersizer 2000 (UK) using the wet method [34,35]. The PXRD analysis of 6-mercaptopurine powder sample was performed with 
the help of Rigaku MiniFlex-II Desktop X-ray diffractometer (Japan) 
[36,37]. The average size of crystallites was calculated from PXRD 
data using the Scherrer’s formula (1):
G = kλ/βcosθ  (1)
Where G is the crystallite size in nm, k is the equipment constant, 
λ is the radiation wavelength, β is the full width at half maximum 
(FWHM), and θ is the Bragg angle [38]. Similarly, the DSC analysis of 6-mercaptopurine was performed with the help of DSC Q200, 
TA Instruments.  The TGA/DTG thermograms of 6-mercaptopurine 
were obtained with the help of TGA Q50 TA instruments [28,29]. 
The % change in particle size, specific surface area (SSA), peak 
intensity, crystallite size, melting point, latent heat, weight loss 
and the maximum thermal degradation temperature (T
max
) of the 
Biofield Energy Treated sample was calculated compared with the 
control sample using the following equation 2:
[ ] % *100Treated ControlChange
Control
−
=
             (2)
Results and Discussion
Particle Size Analysis (PSA)
Table 1: Particle size distribution and surface area of the control and Biofield Energy Treated 6-mercaptopurine. d10, d50, 
and d90: particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution, SSA: the specific surface 
area, and D (4,3): the average mass-volume diameter.
Parameter d10 (µm) d50 (µm) d90 (µm) D (4,3) (µm) SSA (m2/g)Control 31.78 90.23 177.5 98.48 0.105
Biofield Treated 29.96 85.57 170.85 94.02 0.11
Percent change (%) -5.72 -5.16 -3.75 -4.54 4.76
The particle size at d10, d50, d90, and D (4,3) and surface 
area analysis of both the control and Biofield Energy Treated mercaptopurine powder samples were performed, and the data 
are presented in Table 1. The particle size values of the control powder sample at d10, d50, d90, and D (4,3) were 31.78µm, 90.23µm, 
177.5µm, and 98.48µm, respectively. Likewise, the particle sizes of the treated powder sample at d10, d50, d90, and D (4,3) were 29.96µm, 85.57µm, 170.85µm, and 94.02µm, respectively. The 
particle size values in the treated mercaptopurine powder sample 
were significantly decreased by 5.72%, 5.16%, 3.75%, and 4.54% 
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at d10, d50, d90, and D(4,3) compared to the control sample. The 
specific surface area (SSA) of the treated mercaptopurine powder (0.11m2/g) was increased by 4.76% compared to the control sample (0.105m2/g). From the result, it can be assumed that the 
Biofield Energy Treatment might be acting as an external force for the breaking of the larger particles into smaller one, hence 
increased the surface area. The particle size, shape, and surface area have a huge impact on the solubility, dissolution rate, absorption, 
bioavailability, and therapeutic efficacy of a pharmaceutical 
compound [13,39]. The solubility of mercaptopurine is very poor in water, chloroform, acetone, and diethyl ether, whereas slightly soluble in dilute sulphuric acid [12]. Therefore, it was predicted 
that the Biofield Energy Treated 6-mercaptopurine would show the better therapeutic properties by increasing solubility, dissolution, and absorption. It would be better for the pharmaceutical manufacturing industries using it as a raw material for the 
formulation (Table 1).
Powder X-ray Diffraction (PXRD) Analysis
The PXRD diffractograms of the control and Consciousness 
Energy Healing Treated powder samples showed sharp and intense 
peaks (Figure 1) (Table 2) indicated that both the samples were crystalline. The peak intensities of the Consciousness Energy 
Healing Treated sample were significantly altered compared to 
the control sample. Both the control and Biofield Energy Treated samples showed the highest peak intensity at 2θ near to 27.5° 
(Table 2, entry 10). The total peak intensities of the Consciousness 
Energy Healing Treated sample were significantly altered ranging 
from -25% to 14.12% compared to the control sample. Similarly, the 
crystallite sizes of the treated mercaptopurine were significantly 
altered ranging from -35.09% to 71.3% compared to the control 
sample. However, the average crystallite size of the Biofield Energy 
Treated mercaptopurine powder (299.8nm) was decreased by 
2.77% compared with the control sample (299.8nm).
Figure 1: PXRD diffractograms of the control and Biofield Energy Treated 6-mercaptopurine.
Table 2: PXRD data for the control and Biofield Energy Treated 6-mercaptopurine.
Entry No. Bragg angle (°2θ) Peak Intensity (%) Crystallite size (G, nm)
Control Treated Control Treated % change a Control Treated % change b1 11.7 11.74 116 128 10.34 311 320 2.892 12.74 12.77 58 48 -17.24 493 340 -31.03
3 14.47 14.51 307 317 3.26 289 288 -0.354 15.26 15.28 84 82 -2.38 333 349 4.85 16.76 16.7 33.5 35.8 6.87 341 354 3.81
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6 20.48 20.44 85 97 14.12 271 240 -11.44
7 23.41 23.41 238 221 -7.14 308 323 4.878 25.09 25.18 192 180 -6.25 368 342 -7.079 25.74 25.75 177 151 -14.69 304 322 5.9210 27.46 27.48 506 480 -5.14 265 285 7.5511 29.31 29.3 170 164 -3.53 256 263 2.7312 30.3 30.32 147 146 -0.68 299 311 4.01
13 32.4 32.42 65 64 -1.54 320 314 -1.8814 33.11 33.08 48 43 -10.42 297 286 -3.715 35.18 35.17 33.5 35.9 7.16 319 304 -4.716 35.81 35.88 64 58 -9.38 252 264 4.76
17 39.34 39.35 51 53 3.92 315 285 -9.5218 42.28 42.34 23 26 13.04 493 320 -35.0919 46.32 46.27 40 30 -25 218 289 32.5720 47.61 47.7 61 59 -3.28 115 197 71.321 Average crystallite size 308.35 299.8 -2.77
adenotes the % change in the peak intensity of Biofield Energy Treated sample with respect to the control sample; 
bdenotes the % change in the crystallite size of Biofield Energy Treated sample with respect to the control sample.The peak intensity of each diffraction face on the crystalline compound changes according to the crystal morphology [40] and 
alterations in the XRD pattern provide the evidence of polymorphic 
transitions [41,42]. Any change observed in the crystallite sizes 
and peak intensities indicated the modification of the crystal 
morphology of the Biofield Energy Treated mercaptopurine compared to the control sample. The Trivedi Effect®-Consciousness 
Energy Healing Treatment  probably produced the new polymorphic 
form of 6 mercaptopurine through the Biofield Energy via neutrino oscillations [18]. Thus, the treated mercaptopurine might have 
shown the significant effects on the drug performance, such as 
bioavailability, therapeutic efficacy, and toxicity, because of their physicochemical properties like melting point, energy, stability, and 
solubility, are different from the original form [43,44] (Table 2).
Differential Scanning Calorimetry (DSC) Analysis 
Figure 2: DSC thermograms of the control and Biofield Energy Treated mercaptopurine.
The DSC thermograms of both the control and Biofield Energy Treated sample showed the two sharp endothermic peaks in the 
thermograms (Figure 2). The control and Biofield Energy Treated samples showed the 1st endothermic peak at 174.73 °C and 175.14 
°C, respectively due to the evaporation of the bounded water. Similarly, the 2nd endothermic peak of the control and Biofield 
Energy Treated mercaptopurine samples was observed at 331.13 °C 
and 330.4 °C, respectively indicated the melting point. The thermal analysis data closely matched to the literature reported data [44]. 
The evaporation temperature and latent heat of evaporation (∆H 
evaporation) of the Biofield Energy Treated mercaptopurine were 
slightly increased by 0.23% and 3.05%, respectively compared with 
the control sample (Table 3).
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Table 3: DSC data for both control and Biofield Energy Treated samples of mercaptopurine.
Sample Evaporation Temp (°C) Melting Point (°C) ∆H (J/g)   Evaporation FusionControl Sample 174.73 331.13 304.9 169.7
Biofield Energy Treated 175.14 330.4 314.2 102.7
% Change* 0.23 -0.22 3.05 -39.48
ΔH: Latent heat of evaporation/decomposition, *denotes the % change of the Biofield Energy Treated mercaptopurine 
with respect to the control sample.
However, the melting point and latent heat of fusion (∆H fusion) 
of the Biofield Energy Treated mercaptopurine was decreased by 
-0.22% and -39.48% compared with the control sample (Table 
3). Any change in the latent heat of fusion can be attributed to the 
disrupted molecular chains and the crystal structure [45]. From the results, it can be assumed that the Trivedi Effect® -Consciousness 
Energy Healing Treatment might have disrupted the molecular chains and crystal structure of mercaptopurine. hence, the thermal stability of the treated 6-mercaptopurine sample was decreased compared to the control sample.
Thermal Gravimetric Analysis (TGA) / Differential Ther-
mogravimetric Analysis (DTG)
The thermograms of the control and Biofield Energy Treated 
samples showed three steps of thermal degradation (Figure 3). The 
total weight loss of the treated 6-mercaptopurine was significantly 
increased by 9.72% compared to the control sample (Table 4). 
Therefore, the residue amount was significantly decreased by 
79.89% in the Biofield Energy Treated 6-mercaptopurine compared 
to the control sample (Table 4).
Figure 3: TGA thermograms of the control and Biofield Energy Treated mercaptopurine.
Table 4: TGA/DTG data of the control and Biofield Energy Treated samples of mercaptopurine.
Sample TGA DTG; Tmax (°C)
Total weight loss (%) Residue % 1st Peak 2nd Peak 3rd Peak
Control 89.15 10.85 160.61 332.3 650.1
Biofield Energy Treated 97.818 2.182 163.08 332.8 686.3
% Change* 9.72 -79.89 1.54 0.13 5.56
*denotes the % change of the Biofield Energy Treated sample with respect to the control sample, Tmax = the temperature 
at which maximum weight loss takes place in TG or peak temperature in DTG.
The DTG of the control and Biofield Energy Treated 6-mercaptopurine also showed three peaks in the thermograms 
(Figure 4). The maximum thermal degradation temperature 
(Tmax) of the 1st, 2nd, and 3rd peaks of the Biofield Energy Treated 
sample altered by 1.54%, 0.13%, and 5.56% compared with the 
control sample (Table 4). Overall, TGA/DTG data of mercaptopurine 
samples revealed that the thermal stability of the Biofield Energy Treated 6-mercaptopurine sample was increased compared with the control sample.
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Figure 4: DTG thermograms of the control and Biofield Energy Treated mercaptopurine.
ConclusionThe Trivedi Effect®-Consciousness Energy Healing Treatment 
has a significant effect on the particle size, surface area, crystallite 
size, and thermal properties of 6-mercaptopurine. The particle 
size values in the Consciousness Energy Healing Treated powder 
sample were significantly decreased by 5.72%, 5.16%, 3.75%, 
and 4.54% at d10, d50, d90, and D (4,3) compared to the control 
sample. Therefore, the specific surface area of the Biofield Energy 
Treated powder sample was increased by 4.76% compared to the 
control sample. The PXRD peak intensities and crystallite sizes of 
the treated sample were significantly altered ranging from -25% 
to 14.12% and -35.09% to 71.3%, respectively compared to the 
control sample. Unlike particle sizes, the average crystallite size 
of the Biofield Energy Treated sample was decreased by 2.77% compared with the control sample. The evaporation temperature 
and ∆Hevaporation of the Biofield Energy Treated sample were 
slightly increased by 0.23% and 3.05%, respectively compared with 
the control sample. However, the melting point and ∆H fusion of 
the Biofield Energy Treated sample was decreased by -0.22% and 
-39.48% compared with the control sample. The total weight loss 
was significantly increased by 9.72%; hence the residue amount 
was significantly decreased by 79.89% in the Biofield Energy 
Treated sample compared with the control sample. The Tmax of the 1st, 2nd, and 3rd peaks of the Biofield Energy Treated sample 
were increased by 1.54%, 0.13%, and 5.56% compared with the 
control sample. From the overall results, it was concluded that the Trivedi Effect®-Consciousness Energy Healing Treatment might have generated a new polymorphic form of 6-mercaptopurine which may offer better solubility, dissolution, absorption, and 
bioavailability compared with the control sample. The Biofield Energy Treated 6-mercaptopurine would be very useful to design better pharmaceutical formulations that might offer better therapeutic response against acute lymphocytic leukemia, chronic myeloid leukemia, ulcerative colitis, Crohn’s disease, and autoimmune diseases.
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